Direct-acting Antiviral Agents for the Treatment of Chronic Hepatitis C Virus Infection

Hepatitis C virus (HCV) is a leading cause of cirrhosis and hepatocellular carcinoma (HCC) in the US and Japan. Therefore, eradication of HCV may reduce the occurrence of HCC in HCV-infected individuals. In 2011, the use of first-generation HCV NS3/4A protease inhibitors such as telaprevir and bocep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Nakamoto, Shingo, Nakamura, Masato, Jiang, Xia, Miyamura, Tatsuo, Wu, Shuang, Yokosuka, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Ltd 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521257/
https://www.ncbi.nlm.nih.gov/pubmed/26356295
http://dx.doi.org/10.14218/JCTH.2013.00025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521257/
https://www.ncbi.nlm.nih.gov/pubmed/26356295
http://dx.doi.org/10.14218/JCTH.2013.00025

Ejemplares similares